The GLP-1 receptor agonist mechanism directly affects gut motility, and systems that are already dysregulated respond more dramatically to further manipulation
Despite significant improvements in patient prognosis over recent decades through therapeutic advancesincluding proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), monoclonal antibodies, bispecific antibodies, and chimeric antigen receptor T-cell immunotherapy (CAR-T) (Rajkumar and Kumar, 2020), the disease remains incurable due to inevitable relapse and drug resistance during maintenance therapy
Blood orange is rich in polyphenols that support fat metabolism and insulin sensitivity, lemon extract provides flavonoids that help improve glucose response after meals, and turmeric contains curcumin, a powerful anti-inflammatory compound that supports metabolic health and gut signaling tied to GLP-1 production
In Brazil, the primary patent for semaglutide is set to expire in 2026, paving the way for the introduction of generic drugs into the Brazilian market